Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity

被引:464
作者
Menges, M
Rössner, S
Voigtländer, C
Schindler, H
Kukutsch, NA
Bogdan, C
Erb, K
Schuler, G
Lutz, MB
机构
[1] Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Inst Microbiol Immunol & Hyg, D-91052 Erlangen, Germany
[3] Univ Wurzburg, Ctr Infect Res, D-97070 Wurzburg, Germany
关键词
dendritic cells; EAE; tolerance; IL-10; TNF;
D O I
10.1084/jem.20011341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mature dendritic cells (DCs) are believed to induce T cell immunity, whereas immature DCs induce T cell tolerance. Here we describe that injections of DCs matured with tumor necrosis factor (TNF)-alpha (TNF/DCs) induce antigen-specific protection from experimental autoimmune encephalomyelitis (EAE) in mice. Maturation by TNF-alpha induced high levels of major histocompatibility complex class II and costimulatory molecules on DCs, but they remained weak producers of proinflammatory cytokines. One injection of such TNF/DCs pulsed with auto-antigenic peptide ameliorated the disease score of EAE. This could not be observed with immature DCs or DCs matured with lipopolysaccharide (LPS) plus anti-CD40. Three consecutive injections of peptide-pulsed TNF/DCs derived from wild-type led to the induction of peptide-specific predominantly interleukin (IL)-10-producing CD4(+) T cells and complete protection from EAE. Blocking of IL-10 in vivo could only partially restore the susceptibility to EAE, suggesting an important but not exclusive role of IL-10 for EAE prevention. Notably, the protection was peptide specific, as TNF/DCs pulsed with unrelated peptide could not prevent EAE. In conclusion, this study describes that stimulation by TNF-alpha results in incompletely matured DCs (semi-mature DCs) which induce peptide-specific IL-10-producing T cells in vivo and prevent EAE.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 39 条
  • [1] ABKARI O, 2001, NAT IMMUNOL, V2, P725
  • [2] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [3] Regulatory activity of autocrine IL-10 on dendritic cell functions
    Corinti, S
    Albanesi, C
    la Sala, A
    Pastore, S
    Girolomoni, G
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (07) : 4312 - 4318
  • [4] de Saint-Vis B, 1998, J IMMUNOL, V160, P1666
  • [5] Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
    Dhodapkar, MV
    Steinman, RM
    Krasovsky, J
    Munz, C
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 233 - 238
  • [6] Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood
    Dieckmann, D
    Plottner, H
    Berchtold, S
    Berger, T
    Schuler, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) : 1303 - 1310
  • [7] INDUCTION OF HAPTEN-SPECIFIC TOLERANCE BY INTERLEUKIN-10 IN-VIVO
    ENK, AH
    SALOGA, J
    BECKER, D
    MOHAMADZADEH, M
    KNOP, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1397 - 1402
  • [8] Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells
    Fiebiger, E
    Meraner, P
    Weber, E
    Fang, IF
    Stingl, G
    Ploegh, H
    Maurer, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) : 881 - 892
  • [9] CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
    Förster, R
    Schubel, A
    Breitfeld, D
    Kremmer, E
    Renner-Müller, I
    Wolf, E
    Lipp, M
    [J]. CELL, 1999, 99 (01) : 23 - 33
  • [10] Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80(dim), CD86(-)) prolong cardiac allograft survival in nonimmunosuppressed recipients
    Fu, FM
    Li, YP
    Qian, SG
    Lu, LN
    Chambers, F
    Starzl, TE
    Fung, JJ
    Thomson, AW
    [J]. TRANSPLANTATION, 1996, 62 (05) : 659 - 665